1887
  1. Home
  2. Eurosurveillance
  3. Volume 20, Issue 47, 26/Nov/2015
  4. Article
Systematic Review Open Access
Like 0
Download

Abstract

International travel is considered to be an important risk factor for acquisition of multidrug-resistant (MRE). The aim of this systematic review was to determine the effect of international travel on the risk of post-travel faecal carriage of MRE. Secondary outcomes were risk factors for acquisition of MRE. A systematic search for relevant literature in seven international databases was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Articles needed to report on (i) foreign travel, (ii) screening of asymptomatic participants, (iii) antimicrobial susceptibility data and (iv) faecal carriage. Two researchers independently screened the abstracts, assessed the full article texts for eligibility and selected or rejected them for inclusion in the systematic review. In case of disagreement, a third researcher decided on inclusion. Eleven studies were identified. In all studies, a high prevalence (> 20%) of carriage of MRE after international travel was found. The highest prevalence was observed in travellers returning from southern Asia. Foreign travel was associated with an increased risk of carriage of MRE. Further research is needed to assess if this leads to an increase in the number of infections with MRE. Systematic review registration number: PROSPERO CRD42015024973.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2015.20.47.30074
2015-11-26
2024-04-19
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2015.20.47.30074
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/20/47/eurosurv-20-47-4.html?itemId=/content/10.2807/1560-7917.ES.2015.20.47.30074&mimeType=html&fmt=ahah

References

  1. World Tourism Organization (UNWTO). UNWTO tourism highlights, 2014 edition. Madrid: UNTWO; 2014. Available from: http://www.e-unwto.org/doi/pdf/10.18111/9789284416226
  2. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354(2):119-30.  https://doi.org/10.1056/NEJMoa051331  PMID: 16407507 
  3. Steffen R, deBernardis C, Baños A. Travel epidemiology--a global perspective. Int J Antimicrob Agents. 2003;21(2):89-95.  https://doi.org/10.1016/S0924-8579(02)00293-5  PMID: 12615369 
  4. Chen LH, Wilson ME. The role of the traveler in emerging infections and magnitude of travel. Med Clin North Am. 2008;92(6):1409-32.
  5. Wilson ME. The traveller and emerging infections: sentinel, courier, transmitter. J Appl Microbiol. 2003;94 Suppl;1S-11S.  https://doi.org/10.1046/j.1365-2672.94.s1.1.x  PMID: 12675931 
  6. Woodford N. Unwanted souvenirs: travel and multi-resistant bacteria. J Travel Med. 2011;18(5):297-8.  https://doi.org/10.1111/j.1708-8305.2011.00541.x  PMID: 21896091 
  7. Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013;26(4):744-58.  https://doi.org/10.1128/CMR.00023-13  PMID: 24092853 
  8. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597-602.  https://doi.org/10.1016/S1473-3099(10)70143-2  PMID: 20705517 
  9. Oteo J, Pérez-Vázquez M, Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010;23(4):320-6.  https://doi.org/10.1097/QCO.0b013e3283398dc1  PMID: 20614578 
  10. Lausch KR, Fuursted K, Larsen CS, Storgaard M. Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel: a cross-sectional study. Travel Med Infect Dis. 2013;11(5):320-3.  https://doi.org/10.1016/j.tmaid.2013.06.004  PMID: 23810306 
  11. Søraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country. PLoS ONE. 2013;8(7):e69581.  https://doi.org/10.1371/journal.pone.0069581  PMID: 23936052 
  12. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect. 2008;57(6):441-8.  https://doi.org/10.1016/j.jinf.2008.09.034  PMID: 18990451 
  13. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.  https://doi.org/10.1186/2046-4053-4-1  PMID: 25554246 
  14. United Nations Statistics Division (UNSTATS). Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. New York: UNSTATS. [Accessed: 1 Jun 2015]
  15. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296.  https://doi.org/10.1371/journal.pmed.0040296  PMID: 17941714 
  16. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007;36(3):666-76.  https://doi.org/10.1093/ije/dym018  PMID: 17470488 
  17. Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564-8.  https://doi.org/10.1128/AAC.00220-10  PMID: 20547788 
  18. Kennedy K, Collignon P. Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis. 2010;29(12):1501-6.  https://doi.org/10.1007/s10096-010-1031-y  PMID: 20835879 
  19. Ostholm-Balkhed A, Tärnberg M, Nilsson M, Nilsson LE, Hanberger H, Hällgren A, et al. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother. 2013;68(9):2144-53.  https://doi.org/10.1093/jac/dkt167  PMID: 23674762 
  20. Kantele A, Lääveri T, Mero S, Vilkman K, Pakkanen SH, Ollgren J, et al. Antimicrobials increase travelers’ risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60(6):837-46. PMID:25613287 https://doi.org/\\ 
  21. Weisenberg SA, Mediavilla JR, Chen L, Alexander EL, Rhee KY, Kreiswirth BN, et al. Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City. PLoS ONE. 2012;7(9):e45141.  https://doi.org/\\  PMID: 23028808 
  22. Angelin M, Forsell J, Granlund M, Evengård B, Palmgren H, Johansson A. Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: A prospective study. Travel Med Infect Dis. 2015;13(3):223-9.  https://doi.org/10.1016/j.tmaid.2015.04.007  PMID: 25982453 
  23. von Wintersdorff CJ, Penders J, Stobberingh EE, Oude Lashof AM, Hoebe CJ, Savelkoul PH, et al. High rates of antimicrobial drug resistance gene acquisition after international travel, The Netherlands. Emerg Infect Dis. 2014;20(4):649-57.  https://doi.org/10.3201/eid2004.131718  PMID: 24655888 
  24. Paltansing S, Vlot JA, Kraakman ME, Mesman R, Bruijning ML, Bernards AT, et al. Extended-spectrum β-lactamase-producing enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis. 2013;19(8):1206-13.  https://doi.org/10.3201/eid1908.130257  PMID: 23885972 
  25. Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, et al. High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics. Clin Infect Dis. 2015;61(4):593-600.  https://doi.org/10.1093/cid/civ333  PMID: 25904368 
  26. Kuenzli E, Jaeger VK, Frei R, Neumayr A, DeCrom S, Haller S, et al. High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC Infect Dis. 2014;14(1):528.  https://doi.org/10.1186/1471-2334-14-528  PMID: 25270732 
  27. Lübbert C, Straube L, Stein C, Makarewicz O, Schubert S, Mössner J, et al. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol. 2015;305(1):148-56.  https://doi.org/\\  PMID: 25547265 
  28. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60(5):913-20.  https://doi.org/10.1093/jac/dkm318  PMID: 17848376 
  29. Epelboin L, Robert J, Tsyrina-Kouyoumdjian E, Laouira S, Meyssonnier V, Caumes EMDR-GNB Travel Working Group. High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: A Cross-Sectional Cohort Study. J Travel Med. 2015;22(5):292-9.  https://doi.org/10.1111/jtm.12211  PMID: 25997830 
  30. Kaspar T, Schweiger A, Droz S, Marschall J. Colonization with resistant microorganisms in patients transferred from abroad: who needs to be screened? Antimicrob Resist Infect Control. 2015;4(1):31.  https://doi.org/10.1186/s13756-015-0071-6  PMID: 26213620 
  31. Lepelletier D, Andremont A, Grandbastien BNational Working Group. Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread. J Travel Med. 2011;18(5):344-51.  https://doi.org/10.1111/j.1708-8305.2011.00547.x  PMID: 21896099 
  32. Carattoli A. Plasmids and the spread of resistance. Int J Med Microbiol. 2013;303(6-7):298-304.  https://doi.org/10.1016/j.ijmm.2013.02.001  PMID: 23499304 
  33. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011;11(5):355-62.  https://doi.org/10.1016/S1473-3099(11)70059-7  PMID: 21478057 
  34. van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother. 2012;67(9):2090-100.  https://doi.org/\\  PMID: 22678728 
  35. Ruppé E, Armand-Lefèvre L, Estellat C, El-Mniai A, Boussadia Y, Consigny PH, et al. Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Euro Surveill. 2014;19(14):20768.  https://doi.org/10.2807/1560-7917.ES2014.19.14.20768  PMID: 24739981 
  36. Penders J. Acquisition of ESBL‐ and carbapenemase‐producing Enterobacteriaceae during travel: The Carriage of Multiresistant Bacteria After Travel (COMBAT) Study. Maastricht: 3rd Euregional Maastricht Symposium on Immune Compromised Traveller; 2014. Available from: http://www.minc.eu/eumict/3rd%20EUMICT_11_Penders.pdf
  37. Morrison BJ, Rubin JE. Carbapenemase producing bacteria in the food supply escaping detection. PLoS ONE. 2015;10(5):e0126717.  https://doi.org/10.1371/journal.pone.0126717  PMID: 25966303 
  38. Arcilla MS, van Hattem JM, Bootsma MC, van Genderen PJ, Goorhuis A, Schultsz C, et al. The Carriage Of Multiresistant Bacteria After Travel (COMBAT) prospective cohort study: methodology and design. BMC Public Health. 2014;14(1):410. https://doi.org/\\ 
International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Robert+Jan+Hassing&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hassing Robert Jan</a>, <a href="/search?value1=Jelmer+Alsma&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Alsma Jelmer</a>, <a href="/search?value1=Maris+S.+Arcilla&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Arcilla Maris S.</a>, <a href="/search?value1=Perry+J.+van+Genderen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van Genderen Perry J.</a>, <a href="/search?value1=Bruno+H.+Stricker&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Stricker Bruno H.</a>, <a href="/search?value1=Annelies+Verbon&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Verbon Annelies</a></span>. International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review. <a href="/content/ecdc">Euro Surveill.</a> 2015;20(47):pii=30074. <a href="https://doi.org/10.2807/1560-7917.ES.2015.20.47.30074" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2015.20.47.30074</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 10 Mar 2015;&nbsp;&nbsp; <span class="generated">Accepted</span>: 23 Sept 2015 </span> </p>
/content/10.2807/1560-7917.ES.2015.20.47.30074
/content/10.2807/1560-7917.ES.2015.20.47.30074
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error